CLOV CLOVER HEALTH INV CORP

Counterpart Health Signs Multi-Year Agreement with Southern Illinois Healthcare

Counterpart Health Signs Multi-Year Agreement with Southern Illinois Healthcare

WILMINGTON, Del., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced a strategic, multi-year agreement with Southern Illinois Healthcare (SIH), a regional leader in healthcare delivery and the largest health system in Southern Illinois. Counterpart is a subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”).

This partnership will enable SIH’s care teams to excel in value-based care arrangements by equipping them with Counterpart Assistant, a cloud-based AI platform seamlessly integrated into their existing EPIC electronic health record (EHR) system. Counterpart Assistant delivers real-time, patient-specific insights directly within physicians’ workflows, ensuring clinical decisions are guided by actionable, data-driven insights that prioritize patient outcomes. By focusing on improving care delivery, physicians can naturally achieve the key metrics required for success in value-based agreements without added complexity or administrative burden.

“Southern Illinois Healthcare has always been committed to providing exceptional care, particularly in the rural communities we serve,” said SIH President and CEO John Antes. “Counterpart Assistant’s ability to deliver insights at the point of care helps us achieve better outcomes for our patients while enabling success in value-based arrangements. This partnership reinforces our mission to deliver top-quality care in the most efficient, patient-centered way possible.”

Value-based care agreements require meeting specific health plan metrics, which are often tedious to manage alongside direct patient care. Counterpart Assistant simplifies this process by presenting relevant clinical insights in the context of care delivery, ensuring that improved patient outcomes naturally align with performance targets. With earlier diagnoses, better chronic disease management, and streamlined workflows, SIH’s clinicians can focus on caring for their patients, while seamlessly excelling in value-based care programs.

“Southern Illinois Healthcare’s reputation for clinical excellence makes them an ideal partner as we work to enhance value-based care delivery,” said Aric Sharp, CEO of Value-Based Care for Clover Health. “Counterpart Assistant enables providers to focus on improving patient outcomes, and the resulting performance in value-based metrics becomes a natural byproduct of this patient-first approach.”

By leveraging Counterpart Health’s proprietary AI and machine learning capabilities, SIH is advancing its ability to deliver superior patient outcomes while navigating the increasing complexity of value-based care agreements with confidence and ease.

For more information on how Counterpart Health supports physicians in value-based care arrangements, visit .

About Counterpart Health

, a subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), or Clover Health, is a leading AI powered physician enablement platform. Counterpart Health’s flagship software platform, Counterpart Assistant, was incubated by Clover Health as Clover Assistant and has helped improve plan performance and clinical outcomes for Medicare members through proprietary AI technology. Counterpart Health extends the benefits of the data-driven technology platform outside of Clover Health’s Medicare Advantage plan to a wider audience, to enable enhanced patient outcomes and reduced healthcare costs nationwide. Clover Health has published data demonstrating the technology’s impact on , as well as the earlier identification and management of and .

About Southern Illinois Healthcare

Based in Carbondale, Ill., Southern Illinois Healthcare (SIH) is a not-for-profit health system serving the southernmost 16 counties with four hospitals and the region’s only , , , and pediatric unit. The organization is also home to the , the only non-state operated inpatient behavioral health unit south of Interstate 64. With over 670 employed and affiliated physicians and advanced practice providers in 60 specialties and subspecialties, SIH also operates more than 30 clinics throughout its primary and secondary service areas.

SIH is the region’s largest private employer with more than 4,000 employees. With a steadfast mission to provide health care to all people in the communities it serves, SIH is the leading provider of charity care, unreimbursed care and community benefits totaling $1.3 billion since 2014.

Recognized nationally for quality outcomes in heart attack, heart failure, stroke, bariatrics, maternal health, surgical oncology and cancer care, SIH holds affiliations with renowned peers such as Prairie Heart Institute, SIU School of Medicine Family Practice Residency Program, Siteman Cancer Network and the BJC Collaborative.

Press Contact:

Andrew Still-Baxter

Investor Relations Contact:

Ryan Schmidt



EN
05/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provide...

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull ...

 PRESS RELEASE

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcar...

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) i...

 PRESS RELEASE

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Re...

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Thursday, February 26, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter. Fourth Quarter and Full Year 2025 Conference Webcast Detail...

 PRESS RELEASE

Clover Health Announces 53% Growth in Medicare Advantage Membership Du...

Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026 Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong returning member retention, and improving cohort economics position Clover for compounding earnings and margin expansion.Powered by AI, Clover continues to bring industry-leading clinical quality to...

 PRESS RELEASE

Counterpart Health 2025 Results: How Better Clinical Decisions at Scal...

Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomes SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch